
- Pharmaceutical Executive-12-01-2005
- Volume 0
- Issue 0
How Much Do You Really Know About Pharma: Quiz Answers
Find out how you did on our December 2005 quiz.
ANSWERS:
1. The African clawed frog (Xenopus laevis)
2. The researchers rubbed spores of the Penicillium mold into the fabric of their lab coats.
3. Asprin (acetylsalicylic acid)
4. Travelers were to bring back soil samples from the locations they visited. The soil fungus from which Cyclosporine was derived was collected in Norway.
5. Hoffman acetylated morphine, creating heroin.
6. Actually, there were two, Robert Wood Johnson’s brothers James and Edward Mead.
7. Tetracycline
8. Vitamin C (ascorbic acid)
9. “It has not escaped our notice . . .” comes from Watson and Crick’s 1953 Nature article on the structure of DNA. What hadn’t escaped their notice was the fact that the double helix structure they proposed suggested possible copying mechanism for genetic material.
10. Perkins, then 18, was trying to create a synthetic form of quinine.
11. Microbiologist and Nobel Prize winner Selman Waksman discovered streptomycin.
12. Photographer Janet Parker, the world’s last victim of smallpox, died. She apparently was infected by virus that escaped from a laboratory containment.
13. The odd company out is Neutrogena, which is owned by Johnson & Johnson. The rest are part of Pfizer.
14. Sudafed (pseudoephedrine)
15. The Wisconsin Alumni Research Foundation
Articles in this issue
almost 20 years ago
PharmExec's 2006 Forecastalmost 20 years ago
Thought Leader: A Q&A with Graham Allawayalmost 20 years ago
Marketing to Professionals: Appealing to Doctor's Emotionsalmost 20 years ago
The PharmExec 2005 Pipeline Reportalmost 20 years ago
So You Think You Know Pharma?almost 20 years ago
From the Editor: Double-Standard Drugsalmost 20 years ago
Global Report: Wanted: Attentionalmost 20 years ago
Washington Report: Big Productionalmost 20 years ago
Leadership: Where Have All the Heroes Gone?almost 20 years ago
Inside DDMAC: A Conversation with Thomas AbramsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.